92 related articles for article (PubMed ID: 2777189)
1. A comparison of metformin versus guar in combination with sulphonylureas in the treatment of non insulin dependent diabetes.
Wilson JA; Scott MM; Gray RS
Horm Metab Res; 1989 Jun; 21(6):317-9. PubMed ID: 2777189
[TBL] [Abstract][Full Text] [Related]
2. Long term effects of guar gum on metabolic control, serum cholesterol and blood pressure levels in type 2 (non-insulin-dependent) diabetic patients with high blood pressure.
Uusitupa M; Tuomilehto J; Karttunen P; Wolf E
Ann Clin Res; 1984; 16 Suppl 43():126-31. PubMed ID: 6398982
[TBL] [Abstract][Full Text] [Related]
3. Management of type 2 diabetes mellitus with special reference to metformin therapy.
Campbell IW
Diabete Metab; 1991 May; 17(1 Pt 2):191-6. PubMed ID: 1936475
[TBL] [Abstract][Full Text] [Related]
4. Oral antidiabetic combination therapy with sulphonylureas and metformin.
Haupt E; Knick B; Koschinsky T; Liebermeister H; Schneider J; Hirche H
Diabete Metab; 1991 May; 17(1 Pt 2):224-31. PubMed ID: 1936481
[TBL] [Abstract][Full Text] [Related]
5. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
[TBL] [Abstract][Full Text] [Related]
6. Placebo-controlled trial of the effects of guar gum and metformin on fasting blood glucose and serum lipids in obese, type 2 diabetic patients.
Lalor BC; Bhatnagar D; Winocour PH; Ishola M; Arrol S; Brading M; Durrington PN
Diabet Med; 1990; 7(3):242-5. PubMed ID: 2158410
[TBL] [Abstract][Full Text] [Related]
7. Effects of a gel forming dietary fiber, guar gum, on the absorption of glibenclamide and metabolic control and serum lipids in patients with non-insulin-dependent (type 2) diabetes.
Uusitupa M; Södervik H; Silvasti M; Karttunen P
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):153-7. PubMed ID: 2110937
[TBL] [Abstract][Full Text] [Related]
8. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
[TBL] [Abstract][Full Text] [Related]
9. Guar gum is not a panacea in diabetes management.
Carroll DG; Dykes V; Hodgson W
N Z Med J; 1981 May; 93(683):292-4. PubMed ID: 6265843
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus.
González-Ortiz M; Guerrero-Romero JF; Violante-Ortiz R; Wacher-Rodarte N; Martínez-Abundis E; Aguilar-Salinas C; Islas-Andrade S; Arechavaleta-Granell R; González-Canudas J; Rodríguez-Morán M; Zavala-Suárez E; Ramos-Zavala MG; Metha R; Revilla-Monsalve C; Beltrán-Jaramillo TJ
J Diabetes Complications; 2009; 23(6):376-9. PubMed ID: 18849173
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
[TBL] [Abstract][Full Text] [Related]
12. Effects of metformin and glibenclamide alone and in combination on serum lipids and lipoproteins in patients with non-insulin-dependent diabetes mellitus.
Hermann LS; Kjellström T; Nilsson-Ehle P
Diabete Metab; 1991 May; 17(1 Pt 2):174-9. PubMed ID: 1936472
[TBL] [Abstract][Full Text] [Related]
13. Decreased urinary glucose excretion and plasma cholesterol level in non-insulin dependent diabetic patients with guar.
Johansen K
Diabete Metab; 1981 Jun; 7(2):87-90. PubMed ID: 6265299
[TBL] [Abstract][Full Text] [Related]
14. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
[TBL] [Abstract][Full Text] [Related]
15. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
Umpierrez G; Issa M; Vlajnic A
Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
[TBL] [Abstract][Full Text] [Related]
16. Sulfonylurea-metformin-combination versus sulfonylurea-insulin-combination in secondary failures of sulfonylurea monotherapy. Results of a prospective randomized study in 50 patients.
Klein W
Diabete Metab; 1991 May; 17(1 Pt 2):235-40. PubMed ID: 1936483
[TBL] [Abstract][Full Text] [Related]
17. [Effect of guar on lipids, lipoproteins and body weight in patients with primary hyperlipoproteinemia type II].
Arntz HR; Najemnik C; Irsigler K; Hansen W; Vollmar J; Bräuning C
Beitr Infusionther Klin Ernahr; 1983; 12():89-98. PubMed ID: 6316921
[No Abstract] [Full Text] [Related]
18. Effects of low dose guar in non-insulin dependent diabetic patients.
Lim HS; Ee CH; Aw TC
Ann Acad Med Singap; 1990 Jul; 19(4):455-8. PubMed ID: 2221802
[TBL] [Abstract][Full Text] [Related]
19. The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM).
Elkeles RS
Diabete Metab; 1991 May; 17(1 Pt 2):197-200. PubMed ID: 1936476
[TBL] [Abstract][Full Text] [Related]
20. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
